Literature DB >> 16696891

Persuasive evidence that formocresol use in pediatric dentistry is safe.

Alan R Milnes1.   

Abstract

Concern has been expressed about the safety of formocresol use in pediatric dentistry. Formaldehyde, a primary component in formocresol, is a hazardous substance and is considered a probable human carcinogen by Health Canada. However, humans inhale and ingest formaldehyde daily and also produce this compound as part of normal cellular metabolism. The human body is physiologically equipped to handle this exposure through multiple pathways for oxidation of formaldehyde to formate and incorporation into biological macromolecules via tetrahydrofolate-dependent one-carbon biosynthetic pathways. Recent re-evaluation of earlier research that examined potential health risks associated with formaldehyde exposure has shown that the research was based on flawed assumptions, which resulted in erroneous conclusions. This review examines more recent research about formaldehyde metabolism, pharmacokinetics and carcinogenicity, the results of which indicate that formaldehyde is probably not a potent human carcinogen under conditions of low exposure. Extrapolation of these research results to pediatric dentistry suggests an inconsequential risk of carcinogenesis associated with formaldehyde use in pediatric pulp therapy. Areas for further investigation are suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696891

Source DB:  PubMed          Journal:  J Can Dent Assoc        ISSN: 0709-8936            Impact factor:   1.316


  9 in total

1.  Evaluation of the genotoxic effects of formocresol application in vital pulp therapy of primary teeth: a clinical study and meta-analysis.

Authors:  Arnoldo Vasconcelos de Alencar Filho; Valdeci Elias Dos Santos Junior; Merilane da Silva Calixto; Neide Santos; Monica Vilela Heimer; Aronita Rosenblatt
Journal:  Clin Oral Investig       Date:  2018-02-06       Impact factor: 3.573

2.  Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) in vital primary molar pulpotomy.

Authors:  E Yaman; F Görken; A Pinar Erdem; E Sepet; Z Aytepe
Journal:  Eur Arch Paediatr Dent       Date:  2012-08

Review 3.  Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-06

4.  The Clinical, Radiographic and Histological evaluation of three different concentrations of Formocresol as a pulpotomy agent.

Authors:  Swati Goyal; Tasnima Abuwala; Keyur Joshi; Jahnvi Mehta; K R Indushekar; Seema Hallikerimath
Journal:  J Int Oral Health       Date:  2014-04-26

Review 5.  Mineral trioxide aggregate as a pulpotomy medicament: a narrative review.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-03

Review 6.  Pulp treatment for extensive decay in primary teeth.

Authors:  Violaine Smaïl-Faugeron; Anne-Marie Glenny; Frédéric Courson; Pierre Durieux; Michele Muller-Bolla; Helene Fron Chabouis
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

7.  Antimicrobial activity of filling materials used in primary teeth pulpotomy.

Authors:  Hévelin Couto Pimenta; Álvaro Henrique Borges; Matheus Coelho Bandeca; Ana Thereza Sabóia Neves; Rodrigo Gusmão Fontes; Priscila Vieira da Silva; Andreza Maria Fábio Aranha
Journal:  J Int Oral Health       Date:  2015-04

Review 8.  Success Rate of MTA Pulpotomy on Vital Pulp of Primary Molars: A 3-Year Observational Study.

Authors:  Brinda Godhi; Rishi Tyagi
Journal:  Int J Clin Pediatr Dent       Date:  2016-09-27

9.  Evaluation of Biodentine Pulpotomies in Deciduous Molars with Physiological Root Resorption (Stage 3).

Authors:  Hitaf N Nasseh; Balsam El Noueiri; Charles Pilipili; Fouad Ayoub
Journal:  Int J Clin Pediatr Dent       Date:  2018-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.